MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-06-0043897
Cambist Biotech Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹37.88 Lakh
▼ 39% YoY
Net profit · FY 2025
₹79,180
Net margin 2.1%
EBITDA · FY 2025
₹1.99 Lakh
EBITDA margin 5.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹3.15 Lakh
Issued & subscribed
Open charges
₹12 Lakh
Secured borrowings
Company age
20 yrs
Est. 2006
Directors on board
5
As per MCA filings
About Cambist Biotech Private Limited
Data last updated:
Cambist Biotech Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 August 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85121DL2006PTC152725. Its GSTIN is 09AADCC7313C1Z1 (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3.15 Lakh. It is led by directors including Meenakshi Mittal and Priya Tayal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 211 Sarja Market Naharpur Sector – 7 Rohini, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.88 Lakh, a decline of 39% compared to the previous year. For the same year it recorded a net profit of ₹79,180 (net margin 2.1%) and EBITDA of ₹1.99 Lakh (EBITDA margin 5.2%). Revenue has declined at a compounded annual rate (CAGR) of 20% over three years and 10% over five years.
As per MCA filings, the company has open charges of ₹12 Lakh on record.
Cambist Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0043897). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cambistbiotech.com.
Company details
CIN U85121DL2006PTC152725
Registration Number 152725
Incorporation Date 13 August 2006
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0043897
Recognitions & Rankings of Cambist Biotech
Contact details
Cambist Biotech Private Limited's registered office is in Delhi, Delhi. Its website is cambistbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address211 Sarja Market Naharpur Sector – 7 Rohini, Delhi, India – 110085
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cambist Biotech Private Limited, buy the company report.
Comprehensive company report
Cambist Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Cambist Biotech is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Cambist Biotech Private Limited, buy the company report.
Financials of Cambist Biotech Private Limited
FY 2025 filings availableCambist Biotech Private Limited reported revenue of ₹37.88 Lakh (down 39% YoY) for FY 2025.
Revenue · FY 2025
₹37.88 Lakh ▼ 39%
Net profit · FY 2025
₹79,180 margin 2.1%
EBITDA · FY 2025
₹1.99 Lakh margin 5.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 39%
3 years · compounded
▼ 20%
5 years · compounded
▼ 10%
EBITDA CAGR growth
1 year
▼ 16%
3 years · compounded
▼ 10%
5 years · compounded
▼ 5%
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 39% fall in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹79,180 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cambist Biotech Private Limited, buy the company report.
Board of directors of Cambist Biotech Private Limited
Cambist Biotech has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meenakshi Mittal | Director | 28 Jan 2014 | 12 Years 9 Months | Current |
| Priya Tayal | Director | 28 Jan 2014 | 12 Years 9 Months | Current |
| Nitin Tayal | Director | 13 Sep 2006 | 20 Years 1 Months | Current |
| Seema Mohan | Director | 08 Sep 2009 | 17 Years 2 Months | Current |
| Sumesh Mittal | Director | 13 Sep 2006 | 20 Years 1 Months | Current |
Auditor
Cambist Biotech Private Limited is audited by RAJEEV K GARG & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJEEV K GARG & CO | FY 2020 | 009140N |
Shareholding
The shareholding of Cambist Biotech Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Cambist Biotech Private Limited, buy the company report.
Charges & borrowings
Open charges
₹12 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Jun 2020 | 100359386 | Others | ₹2 Lakh | Open | |
| 08 Oct 2018 | 100208197 | Others | ₹10 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Cambist Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cambist Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cambist Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCC7313C1Z1 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cambist Biotech Private Limited, buy the company report.
Recent activity
Cambist Biotech Private Limited has 9 board changes on record since 2006: 5 appointments and 4 cessations. The latest: Meenakshi Mittal ceased to be Additional Director on 26 Sep 2014.
AGM
Cambist Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cambist Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Others amounted to Rs. 2.00 Lakh with Charge ID 100359386 was registered on 22 Jun 2020.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100208197 was registered on 08 Oct 2018.
Ceased
Meenakshi Mittal ceased to be Additional Director.
Ceased
Priya Tayal ceased to be Additional Director.
Appointed
Meenakshi Mittal was appointed as Director.
Appointed
Priya Tayal was appointed as Director.
Ceased
Lalit Kumar ceased to be Director.
Ceased
Jag Mohan ceased to be Director.
Appointed
Seema Mohan was appointed as Director.
Appointed
Nitin Tayal was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Cambist Biotech is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 August 2006 (20+ years old) and is registered under CIN U85121DL2006PTC152725.
Cambist Biotech has 5 current directors:
- Meenakshi Mittal - Director
- Priya Tayal - Director
- Nitin Tayal - Director
- Seema Mohan - Director
- Sumesh Mittal - Director
The latest financial statements of Cambist Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cambist Biotech is 09AADCC7313C1Z1, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Cambist Biotech is U85121DL2006PTC152725. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cambist Biotech was incorporated on 13 August 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
Meenakshi Mittal ceased to be Additional Director on 26 Sep 2014. Priya Tayal ceased to be Additional Director on 26 Sep 2014. Meenakshi Mittal was appointed as Director on 28 Jan 2014. Cambist Biotech has 9 board changes on record in total.
Yes, Cambist Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0043897).
Cambist Biotech can be reached through the website cambistbiotech.com. Its registered office is in Delhi, India.
The registered office of Cambist Biotech is at 211 Sarja Market Naharpur Sector – 7 Rohini, Delhi, India – 110085.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages